Added to YB: 2026-04-03
Pitch date: 2026-04-01
IRIX [bullish]
IRIDEX Corporation
+3.19%
current return
Author Info
Trident Opportunities writes about deep value and special situation investment opportunities. Sign up for the newsletter.
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$17.4M
Pitch Price
$0.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
-21.69
P/E
-3.85
EV/Sales
0.42
Sector
Health Care Equipment and Supplies
Category
turnaround
Portfolioupdate Q1 - 2026 - $IRIX Iridex
IRIX (increased position): Q1 margins lower than expected due to ongoing transition to contract manufacturing, but management expects GPM improvement as overhead decreases. Path to $3M adjusted EBITDA in 2026 on run-rate basis if targets hit. Q1 rev likely weak. Increased position despite near-term headwinds.
Read full article (2 min)